These data confirm the importance of PVC in the induction of a protective effect from severe COVID-19, regardless of current CD4 count, despite the observed dramatic decline of humoral responses, which were on average below the optimal threshold already by four months from the second dose. Here, CD4 is linked to COVID-19.